Monitoring policy in the context of preventive treatment of cardiovascular disease
- 26 October 2022
- journal article
- research article
- Published by Springer Nature in Health Care Management Science
- Vol. 26 (1) , 93-116
Abstract
Preventing chronic diseases is an essential aspect of medical care. To prevent chronic diseases, physicians focus on monitoring their risk factors and prescribing the necessary medication. The optimal monitoring policy depends on the patient’s risk factors and demographics. Monitoring too frequently may be unnecessary and costly; on the other hand, monitoring the patient infrequently means the patient may forgo needed treatment and experience adverse events related to the disease. We propose a finite horizon and finite-state Markov decision process to define monitoring policies. To build our Markov decision process, we estimate stochastic models based on longitudinal observational data from electronic health records for a large cohort of patients seen in the national U.S. Veterans Affairs health system. We use our model to study policies for whether or when to assess the need for cholesterol-lowering medications. We further use our model to investigate the role of gender and race on optimal monitoring policies.Keywords
Funding Information
- National Science Foundation (1552545)
- U.S. Department of Veterans Affairs (15-432)
This publication has 54 references indexed in Scilit:
- Explaining racial and ethnic disparities in cholesterol screeningPreventive Medicine, 2014
- Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patientsEuropean Journal of Operational Research, 2014
- Alleviating the Patient's Price of Privacy Through a Partially Observable Waiting ListManagement Science, 2013
- Exact Goodness‐of‐Fit Tests for Markov ChainsBiometrics, 2013
- Cost Estimation of Cardiovascular Disease Events in the USPharmacoEconomics, 2011
- Estimating Transition Probabilities for Ignorable Intermittent Missing Data in a Discrete-Time Markov ChainCommunications in Statistics - Simulation and Computation, 2010
- Do Statins Reduce Blood Pressure?Hypertension, 2007
- The $64,000 question—What is a quality-adjusted life-year worth?Clinical Therapeutics, 2006
- Apparent and Internal Validity of a Monte Carlo–Markov Model for Cardiovascular Disease in a Cohort Follow-up StudyMedical Decision Making, 2006
- Estimating a Markov Transition Matrix from Observational DataJournal of the Operational Research Society, 1995